BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 29369966)

  • 1. Orally active Epac inhibitor reverses mechanical allodynia and loss of intraepidermal nerve fibers in a mouse model of chemotherapy-induced peripheral neuropathy.
    Singhmar P; Huo X; Li Y; Dougherty PM; Mei F; Cheng X; Heijnen CJ; Kavelaars A
    Pain; 2018 May; 159(5):884-893. PubMed ID: 29369966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy.
    Zhang H; Li Y; de Carvalho-Barbosa M; Kavelaars A; Heijnen CJ; Albrecht PJ; Dougherty PM
    J Pain; 2016 Jul; 17(7):775-86. PubMed ID: 26979998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated Mice.
    Kume M; Ahmad A; DeFea KA; Vagner J; Dussor G; Boitano S; Price TJ
    J Pain; 2023 Nov; 24(11):1980-1993. PubMed ID: 37315729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-specific role of histone deacetylase 6 in chemotherapy-induced mechanical allodynia and loss of intraepidermal nerve fibers.
    Ma J; Trinh RT; Mahant ID; Peng B; Matthias P; Heijnen CJ; Kavelaars A
    Pain; 2019 Dec; 160(12):2877-2890. PubMed ID: 31356453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal Antibody Targeting the Matrix Metalloproteinase 9 Prevents and Reverses Paclitaxel-Induced Peripheral Neuropathy in Mice.
    Tonello R; Lee SH; Berta T
    J Pain; 2019 May; 20(5):515-527. PubMed ID: 30471427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of chemotherapy-induced peripheral neuropathy by the small-molecule inhibitor pifithrin-μ.
    Krukowski K; Nijboer CH; Huo X; Kavelaars A; Heijnen CJ
    Pain; 2015 Nov; 156(11):2184-2192. PubMed ID: 26473292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine Prevents and Reverses Paclitaxel-Induced Mechanical Allodynia in a Mouse Model of CIPN.
    Kyte SL; Toma W; Bagdas D; Meade JA; Schurman LD; Lichtman AH; Chen ZJ; Del Fabbro E; Fang X; Bigbee JW; Damaj MI; Gewirtz DA
    J Pharmacol Exp Ther; 2018 Jan; 364(1):110-119. PubMed ID: 29042416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Axon Integrity to Prevent Chemotherapy-Induced Peripheral Neuropathy.
    Chine VB; Au NPB; Kumar G; Ma CHE
    Mol Neurobiol; 2019 May; 56(5):3244-3259. PubMed ID: 30117103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin educates CD8+ T cells to prevent and resolve chemotherapy-induced peripheral neuropathy in mice.
    Laumet G; Edralin JD; Dantzer R; Heijnen CJ; Kavelaars A
    Pain; 2019 Jun; 160(6):1459-1468. PubMed ID: 30720585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathy.
    Zhang H; Boyette-Davis JA; Kosturakis AK; Li Y; Yoon SY; Walters ET; Dougherty PM
    J Pain; 2013 Oct; 14(10):1031-44. PubMed ID: 23726937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilostazol is an effective causal therapy for preventing paclitaxel-induced peripheral neuropathy by suppression of Schwann cell dedifferentiation.
    Koyanagi M; Imai S; Iwamitsu Y; Matsumoto M; Saigo M; Moriya A; Ogihara T; Nakazato Y; Yonezawa A; Nakagawa S; Nakagawa T; Matsubara K
    Neuropharmacology; 2021 May; 188():108514. PubMed ID: 33684416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage Toll-like Receptor 9 Contributes to Chemotherapy-Induced Neuropathic Pain in Male Mice.
    Luo X; Huh Y; Bang S; He Q; Zhang L; Matsuda M; Ji RR
    J Neurosci; 2019 Aug; 39(35):6848-6864. PubMed ID: 31270160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role for Epac1 in inflammatory pain controlled by GRK2-mediated phosphorylation of Epac1.
    Singhmar P; Huo X; Eijkelkamp N; Berciano SR; Baameur F; Mei FC; Zhu Y; Cheng X; Hawke D; Mayor F; Murga C; Heijnen CJ; Kavelaars A
    Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3036-41. PubMed ID: 26929333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal administration of mesenchymal stem cells reverses chemotherapy-induced peripheral neuropathy in mice.
    Boukelmoune N; Laumet G; Tang Y; Ma J; Mahant I; Singh SK; Nijboer C; Benders M; Kavelaars A; Heijnen CJ
    Brain Behav Immun; 2021 Mar; 93():43-54. PubMed ID: 33316379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of a mitochondria-targeting peptide against paclitaxel-induced peripheral neuropathy.
    Itoh K; Shimoyama M; Schiller PW; Toyama S
    Chem Biol Drug Des; 2023 Apr; 101(4):1012-1018. PubMed ID: 36513390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain.
    Krukowski K; Eijkelkamp N; Laumet G; Hack CE; Li Y; Dougherty PM; Heijnen CJ; Kavelaars A
    J Neurosci; 2016 Oct; 36(43):11074-11083. PubMed ID: 27798187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy.
    Areti A; Komirishetty P; Kalvala AK; Nellaiappan K; Kumar A
    Mol Neurobiol; 2018 Sep; 55(9):7463-7475. PubMed ID: 29427084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-diabetic drug metformin protects against chemotherapy-induced peripheral neuropathy in a mouse model.
    Mao-Ying QL; Kavelaars A; Krukowski K; Huo XJ; Zhou W; Price TJ; Cleeland C; Heijnen CJ
    PLoS One; 2014; 9(6):e100701. PubMed ID: 24955774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy.
    Staurengo-Ferrari L; Bonet IJM; Araldi D; Green PG; Levine JD
    J Neurosci; 2022 Jan; 42(3):405-415. PubMed ID: 34880120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of Gelsemium-based treatment against paclitaxel-induced painful symptoms.
    Vitet L; Patte-Mensah C; Boujedaini N; Mensah-Nyagan AG; Meyer L
    Neurol Sci; 2018 Dec; 39(12):2183-2196. PubMed ID: 30251080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.